Abstract
The lateral mobility of surface receptors can define the signaling properties of a synapse and rapidly change synaptic function. Here we use single-particle tracking with Quantum Dots to follow nicotinic acetylcholine receptors (nAChRs) on the surface of chick ciliary ganglion neurons in culture. We find that both heteropentameric α3-containing receptors (α3*-nAChRs) and homopentameric α7-containing receptors (α7-nAChRs) access synaptic domains by lateral diffusion. They have comparable mobilities and display Brownian motion in extrasynaptic space but are constrained and move more slowly in synaptic space. The two receptor types differ in the nature of their synaptic restraints. Disruption of lipid rafts, PDZ-containing scaffolds, and actin filaments each increase the mobility of α7-nAChRs in synaptic space while collapse of microtubules has no effect. The opposite is seen for α3*-nAChRs where synaptic mobility is increased only by microtubule collapse and not the other manipulations. Other differences are found for regulation of α3*-nAChR and α7-nAChR mobilities in extrasynaptic space. Most striking are effects on the immobile populations of α7-nAChRs and α3*-nAChRs. Disruption of either lipid rafts or PDZ scaffolds renders half of the immobile α3*-nAChRs mobile without changing the proportion of immobile α7-nAChRs. Similar results were obtained with chick sympathetic ganglion neurons, though regulation of receptor mobility differed in at least one respect from that seen with ciliary ganglion neurons. Control of nAChR lateral mobility, therefore, is determined by mechanisms that are domain specific, receptor subtype dependent, and cell-type constrained. The outcome is a system that could tailor nicotinic signaling capabilities to specific needs of individual locations.
Introduction
Nicotinic cholinergic signaling employs the transmitter acetylcholine (ACh) to activate ligand-gated ion channels, termed nicotinic acetylcholine receptors (nAChRs), which are widely distributed in the nervous system. Signaling through nAChRs contributes to a variety of higher-order functions, including learning and memory (Picciotto et al., 1995; Bannon et al., 1998; Marubio et al., 1999; Bitner et al., 2007), and has been implicated in numerous neurodegenerative disorders (Newhouse et al., 1997; Picciotto and Zoli, 2002; Raggenbass and Bertrand, 2002; Teper et al., 2007; Shinawi et al., 2009) as well as addiction (Mansvelder and McGehee, 2002; Maskos et al., 2005; Zhang et al., 2009).
The effectiveness of nicotinic signaling depends critically on nAChR positioning. Presynaptic locations enable the receptors to control transmitter release while postsynaptic locations enable them to modulate transmission in noncholinergic pathways (McGehee et al., 1995; Gray et al., 1996; Alkondon and Albuquerque, 2001; Fabian-Fine et al., 2001; Ji et al., 2001; Le Magueresse et al., 2006; Wanaverbecq et al., 2007; Zhang and Berg, 2007). Positioning relative to intracellular components is also important because nAChR-mediated modulation usually employs calcium-activated mechanisms. Calcium enters directly through homopentameric α7-containing receptors (α7-nAChRs) (Bertrand et al., 1993; Seguela et al., 1993) and can be recruited indirectly by other nAChRs (Dajas-Bailador and Wonnacott, 2004). The modulation achieved depends on the regulatory pathway engaged, and that often depends on the calcium-dependent machinery linked to the nAChR being activated.
Postsynaptic scaffold components and associated transmembrane proteins are likely to help localize nAChRs at synaptic sites (Conroy et al., 2003, 2007; Parker et al., 2004; Temburni et al., 2004; Farías et al., 2007; Rosenberg et al., 2008), but the receptors may remain mobile. Muscle nAChRs are mobile on the cell surface (Anderson and Cohen, 1977; Axelrod et al., 1978; Young and Poo, 1983; Akaaboune et al., 2002), as are neuronal nAChRs (McCann et al., 2008). Rapid lateral mobility of glutamate receptors defines key signaling features at glutamate synapses (Heine et al., 2008; Newpher and Ehlers, 2008; Triller and Choquet, 2008; Makino and Malinow, 2009).
Here we use single-particle-tracking techniques with Quantum Dot (QD) nanocrystals (Heine et al., 2008; Triller and Choquet, 2008) to follow individual nAChRs on the surface of chick ciliary ganglion (CG) neurons in culture. The neurons form nicotinic cholinergic synapses on each other under these conditions and express the same two classes of receptors found in vivo: homopentameric α7-nAChRs and heteropentameric α3*-nAChRs (Margiotta and Berg, 1982; Vernallis et al., 1993; Chen et al., 2001). We find that both classes of receptors slow down when transiting synaptic space. In addition, a fraction of each receptor type is immobile and preferentially localized in synaptic space. Disrupting either the cytoskeleton or postsynaptic scaffolds differentially affects α7-nAChRs and α3*-nAChRs. Similar results were obtained with sympathetic neurons, though one mechanism of receptor restraint differed. Subunit composition and cell type, therefore, can determine the surface fate of nAChRs, linking them to different organizing elements. This, in turn, can provide a mechanism for targeting individual nAChR subtypes to specific job assignments.
Materials and Methods
Cell cultures.
Dissociated embryonic day 8 (E8) chick CG neurons were grown in culture for 6 d on glass bottom culture dishes coated with poly-d-lysine, fibronectin, and lysed fibroblasts at 2 ganglion equivalents per 16 mm coverslip (Nishi and Berg, 1981; Zhang et al., 1994). Dissociated E13 chick sympathetic ganglion neurons from the lumbar region were grown in culture for 6 d on glass bottom culture dishes coated with poly-d-lysine at 1.5 ganglion equivalents per 16 mm coverslip (Downing and Role, 1987).
Transfections.
Neurons were transfected at the time of plating as described previously (Conroy et al., 2003) using the transfection reagent Effectene (0.25–0.5 μg of DNA/well, 1:25 ratio of DNA/Effectene, Qiagen). The medium was replaced 24 h after plating, and cultures were analyzed after 6 d. Typical transfection efficiencies were 1–2%.
Pharmacological manipulations.
Actin filaments were depolymerized by treating cultures with latrunculin A (3 μm) or cytochalasin D (2 μm), and microtubules were depolymerized by treatment with nocodazole (10 μm)—all for 1 h at 37°C in 0.1% DMSO. For cholesterol depletion, cells were incubated for 2.5 h with cholesterol oxidase (COase, 2 U/ml) or with methyl-β-cyclodextrin (MβCD, 3 μm) for 15 min at 37°C.
Single-particle tracking.
QDs (Invitrogen) tethered to individual α3*- and α7-nAChRs via specific biotinylated ligands were used as fluorescent probes to follow the mobility of nAChRs. Synapses were labeled using either FM4-64 dye uptake (5 μm, Invitrogen) or MitoTracker 580 staining (100 nm, Invitrogen). FM4-64 labeling was achieved by a 30 s incubation at room temperature (RT) with 40 mm KCl added to the culture medium to stimulate vesicle recycling. MitoTracker Red 580 staining was performed by adding the reagent to the culture medium for 2 min at 37°C, washing two times with culture media, and leaving the neurons an additional 30 min at 37°C. After rinsing three times with PBS containing 0.1% BSA, neurons were incubated with either biotinylated α-bungarotoxin (Biot-αBgt, 10 nm, Invitrogen) or biotinylated monoclonal antibody (mAb) 35 (Biot-mAb 35, 0.1 μg/ml) for 5 min on ice, washed three times, and then incubated for 5 min with 0.5 nm streptavidin-coated QDs (605 nm) on ice. Neurons were washed three times with recording medium containing the following (in mm): 160 NaCl, 10 HEPES, 10 glucose, 4.5 KCl, 2 CaCl2, and 1 MgCl2, pH 7.4. Negative controls substituted mAb 35 for Biot-mAb 35 (supplemental Fig. 1A,C, available at www.jneurosci.org as supplemental material) and used 100 μm nicotine to compete the Biot-αBgt (supplemental Fig. 2A,C, available at www.jneurosci.org as supplemental material). To minimize tracking internalized QD-nAChRs, all movies were confined to a 20 min period immediately after the labeling (Charrier et al., 2006). Treating the cells with an acid wash (30 s at pH 5.5 at RT) (Ehlers et al., 2007) removed the vast majority of QDs, confirming that little, if any, internalization had occurred (supplemental Figs. 1B,D, 2B,D, available at www.jneurosci.org as supplemental material).
Neurons were imaged with an inverted microscope (Zeiss Axiovert 200M) equipped with a 63× oil-immersion objective (numerical aperture = 1.40). Samples were illuminated with a mercury lamp and imaged with appropriate excitation filters, dichroic mirrors, and emission filters. Settings were HQ545/30, Q565LP, and HQ610/75M, respectively, for FM4-64 and MitoTracker; D420/40×, 470DCXR, and D605/40, respectively, for QD 605; and HQ487/25, Q505LP, and HQ535/40M, respectively, for GFP. Fluorescence images were acquired with 95 ms exposure times at 10 Hz using a CCD camera (AxioCam MRm, Zeiss) and AxioVision 4.6 software (Zeiss).
Single QDs were identified by their characteristic blinking. Tracking of single QDs was performed with the ImageJ (NIH) plugin “SpotTracker” after processing image sequences with the “SpotEnhancing Filter” plugin (Sage et al., 2005). To assign synaptic localizations, trajectories were sorted into extrasynaptic and synaptic bins defined by the mitochondria marker MitoTracker or the FM4-64 dye images. Synaptic spaces for MitoTracker and FM4-64-labeled boutons were defined as punctate regions 3 pixels in diameter (0.2 μm/pixel) (Aravanis et al., 2003). Synaptic and extrasynaptic trajectories were considered for 10 or more consecutive frames each, with the center of the QD inside the respective region. Periods where the fluorescence signal disappeared due to the blinking of single quantum dots were omitted from the analysis. In such cases, the trajectory was reconstructed by joining trajectory fragments immediately before and after the dark period of the blink. Instantaneous diffusion coefficients (Di) were determined for each trajectory as previously described (Gómez-Varela et al., 2010), fitting the first five points of the mean square displacement (MSD) curves versus the lag time. The global localization accuracy was determined by testing the vibrational stability of the setup, calculating MSD for immobile spots. Immobile QDs were defined as streptavidin-QDs stationary on the surface of glass bottom dishes in the absence of neurons. The localization accuracy was 50 nm, and the resolution limit in terms of diffusion coefficients was 0.008 μm2/s.
Synaptic dwell time was calculated as the total time spent by a QD-nAChR in synaptic space divided by the number of exits by the QD from the space. The frequency of transitions represents the sum of entries and exits from synaptic space divided by the duration of the recording period.
Immunostaining and confocal imaging.
To label surface α3*-nAChRs, neurons were lightly fixed with 0.15% paraformaldehyde (PFA) for 20 min at RT, washed in PBS, and incubated with mAb 35 (1:200) for 1 h at RT (Conroy and Berg, 1998). A 45 min incubation with rhodamine-αBgt (100 nm; Invitrogen) was used to label α7-nAChRs before fixation as previously described (Conroy et al., 2003). After washing in PBS, cells were then fixed with 2% PFA in PBS for 20 min at RT. To label synaptic boutons, cells were incubated with the anti-synaptotagmin mAb 48 (1:20; Developmental Studies Hybridoma Bank, University of Iowa Department of Biological Sciences) and anti-SV2 antibody (1:1000; Developmental Studies Hybridoma Bank) overnight at 4°C in PBS containing 5% normal donkey serum and 0.1% Triton X-100. After washing in PBS, cells were incubated with appropriate donkey Cy3- or FITC-conjugated secondary antibody 1 h at RT (1:250, Jackson ImmunoResearch Laboratories), rinsed, and mounted on slides for imaging.
Confocal images were acquired in sequential mode using a Leica SP5 confocal microscope with settings that did not saturate the fluorescence signals and that fulfilled Nyquist sampling criteria. ImageJ software was used for quantifying the labeling intensity and the alignment of receptor clusters with SV2/synaptotagmin puncta. For this analysis, regions of interest (ROIs) of 20 μm were selected on the neurites. ROIs were binarized automatically using the mean of the background value inside the neurite plus two times the SD as an intensity threshold value for defining a cluster or puncta in each image. Clusters/puncta within the ROIs were registered if they had at least 3 × 3 pixels above threshold (pixel diameter: 80 nm). Receptor clusters were considered synaptic if they were ≤2 pixels away from SV2/synaptotagmin puncta. Data are expressed as the mean + SEM per neurite length of 10 μm.
Statistical analysis.
Statistical analysis was assessed with Mann–Whitney U test (MW test) for comparisons of diffusion coefficients if single pairs were involved; Kruskal–Wallis test (KW test) was used for ≥3 values. Student's t test (t test) was used for comparisons of dwell times, numbers of transitions, and immunostaining data if single pairs were involved; one-way ANOVA was used for ≥3 values. The n values report the number of QDs or trajectories examined. *p < 0.05, **p < 0.01, ***p < 0.001.
Materials.
White leghorn chick embryos were obtained locally and maintained at 37°C in a humidified incubator. Biot-mAb 35 was prepared by incubating mAb 35 with a sulfosuccinimidobiotin reagent (Pierce via Thermo Scientific). All reagents were purchased from Sigma unless otherwise indicated. The mAb 48 and SV2 antibodies, developed by L. Reichardt and K. Buckley, respectively, were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa Department of Biology (Iowa City, IA).
Results
Lateral mobility of nicotinic receptors on neurons
To examine the lateral mobility of nAChRs on neurites of CG neurons in culture, we labeled α3*-nAChRs with Biot-mAb 35 and α7-nAChRs with Biot-αBgt. The labeled receptors were then tracked by incubating them with QDs linked to streptavidin. The labeling was specific because few QDs were observed for α3*-nAChR labeling if the Biot-mAb 35 was replaced with unconjugated mAb 35 (supplemental Fig. 1, available at www.jneurosci.org as supplemental material). Similarly, few QDs were observed for α7-nAChR labeling if the Biot-αBgt was competed with nicotine (supplemental Fig. 2, available at www.jneurosci.org as supplemental material). Bound QDs were confirmed as being on the cell surface throughout the imaging period in both cases by showing that they could be readily stripped at the end by acid wash (supplemental Figs. 1, 2, available at www.jneurosci.org as supplemental material).
Focusing on single nAChR-QD complexes as evidenced by their characteristic blinking, we tracked the movement of α3*-nAChRs that crossed a synaptic/extrasynaptic border at least twice during their trajectory (Fig. 1A; supplemental Movie 1, available at www.jneurosci.org as supplemental material). Synaptic sites were identified for this purpose by prelabeling either with FM4-64 uptake or MitoTracker staining. Plots of MSD versus lag time were used to examine mobility quantitatively (Fig. 1B,C). The initial slope yielded the Di for α3*-nAChRs: 0.070 μm2/s in synaptic space and 0.188 μm2/s in extrasynaptic space (Fig. 1D,E) (p < 0.001 for synaptic vs extrasynaptic, MW test). The results were unchanged by a 10-fold reduction in Biot-mAb 35 concentration used to label the receptors, indicating that antibody-receptor cross-linking was unlikely to have skewed the results (data not shown). Thus mobile α3*-nAChRs displayed significantly decreased diffusion rates when in synaptic locations. The linear MSD plot for extrasynaptic space indicated Brownian motion, whereas the asymptotic plot in synaptic space is consistent with constrained motion (Kusumi et al., 1993).
On adult CG neurons in vivo, α7-nAChRs are largely confined to perisynaptic regions (Jacob and Berg, 1983; Wilson Horch and Sargent, 1995; Shoop et al., 1999, 2002). In cell culture, we find that some α7-nAChR puncta on neurites appear to be associated with synaptic sites defined by SV2 and synaptophysin immunostaining (42.4 ± 4.4%, n = 22 image, 3 culture platings) (supplemental Fig. 3, available at www.jneurosci.org as supplemental material), though the staining may reflect in part perisynaptic receptors at the ultrastructural level. QD tracking of mobile α7-nAChRs demonstrated that the receptors traverse both synaptic and extrasynaptic space in neurites and do so with diffusion rates almost equivalent to those found for α3*-nAChRs (Fig. 2A; supplemental Movie 2, available at www.jneurosci.org as supplemental material). The median Di was 0.067 μm2/s for α7-nAChRs at synaptic sites and 0.188 μm2/s in extrasynaptic regions (p < 0.001, MW test). MSD plots again indicated Brownian motion in extrasynaptic space and restricted motion in synaptic space (Fig. 2B,C). Interestingly, α7-nAChRs clearly differed from α3*-nAChRs in the frequency with which they crossed into and out of synaptic space (Fig. 2D): 48.2 ± 2.5 and 36.6 ± 3.0 transitions/min for α3*- and α7-nAChRs, respectively (p < 0.01, t test). They did not show a significant difference in synaptic dwell time: 0.50 ± 0.03 ms and 0.59 ± 0.04 ms for α3*- and α7-nAChRs, respectively (n = 86, 57). Results were the same for synapses marked with MitoTracker staining or with FM4-64 uptake (supplemental Fig. 4, available at www.jneurosci.org as supplemental material).
Most striking, however, was the difference between α3*-nAChRs and α7-nAChRs on the neurites when immobile receptors were considered (Fig. 2D). Only 34 ± 4% of all α3*-nAChRs were mobile compared with 61 ± 3% of α7-nAChRs (p < 0.05, t test). The remainder showed no detectable mobility during the entire time of imaging. Approximately half of the total immobile receptors, both for α3*-nAChRs and for α7-nAChRs, were synaptic (46 and 54%, respectively). Given that synaptic membrane occupies 6.4 ± 0.3% of the neurite surface (n = 5 visual fields of GFP-expressing neurites and MitoTracker-stained synapses), immobile receptors appear to be preferentially concentrated at synapses (≥7-fold in number per unit area over that in extrasynaptic space).
The results indicate that mobile α3*-nAChRs and α7-nAChRs display equivalent diffusion rates in extrasynaptic space and that the synaptic domain restrains their mobility. Additional constraints render a portion of the receptors persistently immobile and collect a significant fraction of such receptors at synapses. This immobility involves a larger fraction of α3*-nAChRs than α7-nAChRs, demonstrating the relevance of subunit composition for nicotinic receptor fate on neurites.
Cytoskeletal determinants of nAChR mobility
Cytoskeletal elements such as microtubules and F-actin can influence the mobility of membrane components on the surface of neurites, differentially affecting receptors in synaptic and extrasynaptic domains (Charrier et al., 2006; Renner et al., 2009). To determine whether microtubules play such a role for nicotinic receptors, we incubated CG neurons with nocodazole (10 μm) for 1 h to depolymerize them and used QD trafficking to follow α3*-nAChRs on the neurite surface. The vehicle, DMSO, had no effect except for a minor slowing of extrasynaptic α3*-nAChRs (supplemental Fig. 5, available at www.jneurosci.org as supplemental material); all subsequent comparisons were made against vehicle-treated controls. Nocodazole increased the mobility of the α3*-nAChRs both in synaptic and extrasynaptic space (Fig. 3A). The median Di values were 0.079 μm2/s and 0.230 μm2/s, respectively; both were significantly different from those in vehicle (p < 0.01 and 0.001; KW test). Microtubule depolymerization also increased the frequency of transitions between the two domains (Fig. 3C): 64 ± 4 and 43 ± 3 transitions/min with and without nocodazole treatment, respectively (p < 0.01; one-way ANOVA). No significant change was seen in the synaptic dwell time (supplemental Fig. 6A, available at www.jneurosci.org as supplemental material). Collapse of filamentous actin (F-actin) by treating with latrunculin A (3 μm) for 1 h also increased the mobility of α3*-nAChRs in extrasynaptic space (Fig. 3A). The median Di was 0.210 μm2/s (p < 0.001 compared to vehicle; KW test). The treatment did not, however, change the fraction of mobile α3*-nAChRs or their synaptic transitions or dwell time (Fig. 3A,C; supplemental Fig. 6A, available at www.jneurosci.org as supplemental material).
Both nocodazole and latrunculin A also affected α7-nAChRs, with only minor differences from that seen for α3*-nAChRs. Thus nocodazole increased the diffusion of α7-nAChRs in extrasynaptic regions; the Di was 0.242 μm2/s (p ≤ 0.001 compared to vehicle; KW test). But unlike its effects of α3*-nAChRs, nocodazole had no effect on α7-nAChR diffusion in synaptic space or on the number of synaptic transitions (Fig. 3B,C; supplemental Fig. 6A, available at www.jneurosci.org as supplemental material). Collapse of F-actin with latrunculin A increased the mobility of α7-nAChRs in both domains (Fig. 3B), whereas only extrasynaptic α3*-nAChRs were affected in this case. Median Di values of 0.078 μm2/s and 0.233 μm2/s were obtained for α7-nAChRs in synaptic and extrasynaptic space, respectively (p < 0.05, p < 0.001 vs vehicle; KW test). As found for nocodazole, latrunculin A had no effect on the frequency of transitions between the two domains (Fig. 3C) or the synaptic dwell time (supplemental Fig. 6A, available at www.jneurosci.org as supplemental material). Neither nocodazole nor latrunculin A treatment changed the proportions of α3*-nAChRs and α7-nAChRs that remained immobile (supplemental Fig. 6B, available at www.jneurosci.org as supplemental material). Cytochalasin, used as an alternative method of disrupting F-actin, similarly failed to alter the proportion of α3*-nAChRs that were mobile (supplemental Fig. 6B, available at www.jneurosci.org as supplemental material).
The results indicate that both microtubules and F-actin influence the mobility of nAChRs on neurites and exert subtle differences depending on synaptic versus extrasynaptic locations for α3*-nAChRs and α7-nAChRs. Neither microtubule nor F-actin constraints, however, can account for the fact that a fraction of α3*-nAChRs and α7-nAChRs are immobile.
Effects of cholesterol depletion on receptor mobility
Lipid rafts, which are membrane microdomains rich in cholesterol and glycosphingolipids, can influence the distribution of surface components (Edidin, 2003; Marguet et al., 2006; Renner et al., 2009). On CG neurons in vivo, lipid rafts engulf and help stabilize α7-nAChRs (Brusés et al., 2001; Liu et al., 2008). We depleted lipid rafts by incubating CG neurons with cholesterol oxidase (COase, 2 U/ml), which catalyzes the oxidation of cholesterol to cholestenone and disperses lipid microdomains (Scheiffele et al., 1997; Harder et al., 1998; Keller and Simons, 1998). The treatment increased the mobility of α3*-nAChRs in the extrasynaptic space (median Di = 0.208 μm2/s; p < 0.01 compared to vehicle; MW test) but had no effect on synaptic α3*-nAChR mobility, transitioning, or dwell time (Fig. 4A,C,D).
In contrast, lipid raft disruption had extensive effects on α7-nAChRs. Diffusion speeds were increased both within and outside of synaptic spaces (Fig. 4B). Median Di values were 0.091 μm2/s and 0.213 μm2/s for synaptic and extrasynaptic space, respectively (p < 0.001, p < 0.01 compared to vehicle; MW test). In addition, α7-nAChRs underwent more transitions into and out of synaptic space (Fig. 4C): 55 ± 4 transitions/min (p < 0.001; t test). They also displayed a reduced dwell time at synapses (Fig. 4D): 0.42 ± 0.02 s (p < 0.001; t test).
Unexpectedly, lipid raft disruption substantially increased the proportion of α3*-nAChRs that displayed mobility (Fig. 4E), increasing it from 34 ± 4% in controls to 54 ± 2% (p < 0.05; t test) on neurites of COase-treated cells. A second method of disrupting lipid rafts, namely treating cells with MβCD, had the same effect as COase; it increased the proportion of mobile α3*-nAChRs to the same extent. COase treatment had no effect on the proportion of α7-nAChRs that were mobile (Fig. 4E). Together, the results indicate multiple effects of the lipid environment on the mobility of nAChRs. It can immobilize a fraction of receptors depending on their subunit composition (e.g., α3*-nAChRs, but not α7-nAChRs) while having little effect on the diffusion of synaptic α3*-nAChRs once mobile. Paradoxically, the lipid raft appears to have greatest effect on the diffusion of α7-nAChRs, retarding them both in synaptic and extrasynaptic space, but apparently does not provide the restraint that holds a fraction of α7-nAChRs immobile on the surface.
Immobility may be the most relevant criterion for stabilizing receptors at postsynaptic sites. The COase treatment, which decreased the number of immobile α3*-nAChRs, also substantially reduced the number of α3*-nAChR clusters on the cell surface (supplemental Fig. 7, available at www.jneurosci.org as supplemental material). These included clusters at synaptic sites as defined by proximity to presumptive presynaptic puncta that costained for SV2 and synaptophysin (Fig. 4F). COase produced no decrement in the number of SV2/synaptophysin puncta, arguing against a major presynaptic effect (6.2 ± 0.6 and 6.5 ± 0.5 for controls and COase, respectively; n = 3 platings). Nor did it reduce the number of α7-nAChR puncta (6.8 ± 0.8 and 7.6 ± 0.5 for controls and COase, respectively; n = 3 platings). No change was seen in the mean size or staining intensity for the remaining puncta in any case (data not shown). The results are most consistent with the lipid environment providing a restraining component that facilitates immobilization of α3*-nAChRs; release of the constraint tips the balance in favor of dispersal and/or removal.
Constraint of nicotinic receptors by the PDZ-containing postsynaptic scaffold
Members of the PSD-95 family of PDZ-containing proteins establish postsynaptic scaffolds associated with nicotinic receptors on neurons and influence their signaling and localization (Conroy et al., 2003, Parker et al., 2004; Temburni et al., 2004; McCann et al., 2008). To test the extent to which these PDZ-proteins may constrain the lateral mobility of nAChRs, we transfected CG neurons with a construct encoding a 9 aa fragment of CRIPT that recognizes the PDZ3 domain of PSD-95 family members and interferes with their ability to form clusters (Passafaro et al., 1999; Conroy et al., 2003). Results were compared both to untransfected controls and to neurons transfected with a construct expressing GFP; no differences were seen between the latter two (supplemental Fig. 8, available at www.jneurosci.org as supplemental material).
CRIPT expression had no effect on the diffusion parameters of mobile α3*-nAChRs (Fig. 5A,B) but clearly increased the diffusion of α7-nAChRs both in synaptic and extrasynaptic space (Fig. 5C; supplemental Movie 3, available at www.jneurosci.org as supplemental material). Median Di values were 0.078 μm2/s and 0.253 μm2/s for synaptic and extrasynaptic space, respectively (p < 0.05, p < 0.001 vs GFP; MW test). No significant differences were seen for α3*-nAChRs or for α7-nAChRs with respect to synaptic dwell time or frequency of transition between synaptic and extrasynaptic space (supplemental Fig. 9, available at www.jneurosci.org as supplemental material). CRIPT expression, however, doubled the fraction of mobile α3*-nAChRs (Fig. 5D), increasing it from 30 ± 5% in controls to 62 ± 2% (p < 0.05, t test) in neurites of CRIPT-transfected neurons. We corroborated the target of CRIPT action as being two specific members of the PSD-95 family: transfecting the neurons with an RNAi construct (PSD-95/SAP102-RNAi) that knocked down PSD-95 and SAP102 levels (Neff et al., 2009) had a similar effect on the α3*-nAChR mobile fraction (Fig. 5D). No additional receptors were mobilized even when the disruptive treatments were combined: CRIPT transfection for PDZ scaffolds, nocodazole for microtubules, latrunculin A for F-actin, and COase for lipid rafts. The proportion of mobile α3*-nAChRs was the same as that seen with CRIPT expression alone (Fig. 5D). Notably, transfecting cells with a SAP102 construct that lacked a GK domain (SAP102-GK) acted as a dominant negative, replicating the effects of PSD-95/SAP102-RNAi; overexpressing full-length SAP102 had no effect (Fig. 5D). None of the treatments produced a change in the fraction of α7-nAChRs that was mobile.
The results show that PDZ-containing proteins differentially affect the mobilities of α3*-nAChRs and α7-nAChRs, effectively discriminating on the basis of subunit composition. They constrain the rates of diffusion for mobile α7-nAChRs but not for mobile α3*-nAChRs, and conversely, they increase the size of the α3*-nAChR immobile fraction via a GK domain without affecting this parameter for α7-nAChRs.
Mobility of α7-nAChRs on chick sympathetic ganglion neurons
To assess the generality of these results, experiments were also performed with chick sympathetic ganglion neurons in culture. The neurons express α7-nAChRs that can be tagged with Biot-αBgt and QDs and followed through synaptic and extrasynaptic spaces on neurites. Analyzing the trajectories and calculating the Di values as described above for CG neurons indicated again a slower mobility for α7-nAChRs in synaptic space, compared to extrasynaptic space (Fig. 6A, supplemental Fig. 10, available at www.jneurosci.org as supplemental material). Di values of 0.064 μm2/s and 0.133 μm2/s were obtained for synaptic and extrasynaptic trajectories, respectively (n = 196, 264). The mean synaptic Dis were equivalent on sympathetic and CG neurites, but the extrasynaptic Dis were different (p < 0.001, MW test). COase treatment produced no change in the mobility of α7-nAChRs either in synaptic or extrasynaptic space, in contrast to its effects on CG neurons (Fig. 6A). Disrupting the actin cytoskeleton with latrunculin A, however, produced increases in the diffusion rates of α7-nAChRs both in synaptic and extrasynaptic space, and the increases were comparable to those seen for α7-nAChRs on CG neurons. The treatments produced no changes in transition frequency or synaptic dwell time (supplemental Fig. 11, available at www.jneurosci.org as supplemental material). The results indicate that the general features of α7-nAChR mobility are common between the two cell types but that regulatory controls can also be cell type specific.
Discussion
The lateral mobility of glutamate receptors on the surface can be a critical determinant shaping synaptic responses (Ehlers et al., 2007; Heine et al., 2008; Kessels and Malinow, 2009; Makino and Malinow, 2009). In addition to this role at nicotinic synapses, nAChR mobility may also determine receptor localization at and modulation of non-nicotinic synapses (McGehee et al., 1995; Gray et al., 1996; Alkondon and Albuquerque, 2001; Fabian-Fine et al., 2001; Ji et al., 2001; Levy and Aoki, 2002; Le Magueresse et al., 2006; Wanaverbecq et al., 2007; Zhang and Berg, 2007). We used QDs for single-particle tracking of nAChRs to examine their mobility on the neuron surface. We find that substantial fractions of both α3*-nAChRs and α7-nAChRs are mobile on the surface, that they are constrained but not immobile when in synaptic space, and that they transition between synaptic and extrasynaptic domains. Both α3*-nAChRs and α7-nAChRs also have substantial proportions of immobile receptors relatively concentrated in synaptic space. Immobile α3*-nAChRs, but not α7-nAChRs, can be liberated in part by disruption of lipid rafts and PDZ scaffolds. These same components, and to a lesser extent cytoskeletal elements, differentially constrain the mobile receptor populations depending on cell type, local domain, and receptor subunit composition. The results demonstrate a multiplicity of factors determining receptor location (Fig. 7).
On mature CG neurons in vivo, α3*-nAChRs, but not α7-nAChRs, are concentrated at postsynaptic densities. Most α7-nAChRs and some α3*-nAChRs are localized on somatic spines embedded within lipid rafts and are activated by “ectopic” release from large calyx-like terminals engulfing the neurons (Jacob and Berg, 1983; Wilson Horch and Sargent, 1995; Shoop et al., 1999, 2002; Brusés et al., 2001; Coggan et al., 2005; Sargent, 2009). Here we examined receptor trafficking on CG neurites that are innervated in culture, as are CG projections at comparable stages in vivo (Landmesser and Pilar, 1972; Liu et al., 2006). Both α3*-nAChRs and α7-nAChRs traverse synaptic space on neurites, but the “synaptic” α7-nAChRs seen here could be perisynaptic at the ultrastructural level; α3*-nAChRs generate most of the synaptic response in culture (Chen et al., 2001; Conroy et al., 2003).
The diffusion rates found here for mobile α3*-nAChRs and α7-nAChRs fall within ranges reported previously for membrane components traversing synapses (Groc and Choquet, 2008). The threefold difference in synaptic vs extrasynaptic diffusion is comparable to that reported both for AMPA receptors (Ehlers et al., 2007) and EAG1 voltage-gated potassium channels (Gómez-Varela et al., 2010). A report that used photobleaching of fluorescent ligands to examine α7-nAChR migration in vivo also found them to be mobile and to exchange between synaptic and extrasynaptic compartments on neurons (McCann et al., 2008).
Most striking was the discovery of immobile α3*-nAChRs preferentially concentrated in synaptic space and that they could be freed up in part by specific treatments. The parallel decrements in immobile α3*-nAChRs and in α3*-nAChRs clusters with COase treatment suggests a functional link between the two. The fact that receptor clusters appeared to be lost “all-or-none,” rather than simply diminishing in size or staining intensity, suggests a lipid-dependent threshold for receptor immobilization.
The postsynaptic membrane complex has previously been shown to contain transmembrane components that restrict diffusion, as well as scaffold networks that anchor receptors (Kim and Sheng, 2004; Charrier et al., 2006; Renner et al., 2009). The latter includes PSD-95 family members that regulate AMPA receptor mobility (Bats et al., 2007). The lipid environment also restricts mobility by increasing local membrane viscosity (Marguet et al., 2006; Allen et al., 2007) and by concentrating components that tether receptors, such as palmitoylated PSD-95 and the sequestration of AMPA receptors (El-Husseini et al., 2002). Links to the cytoskeleton help secure the postsynaptic membrane complex (Feng and Zhang, 2009).
The methods used here to depolymerize microtubules, collapse F-actin, and disrupt PDZ scaffolds containing PSD-95 family members are relatively specific and commonly used. Disruption of lipid rafts was achieved either with COase to destroy cholesterol or incubation with MβCD. COase treatment is a gentle strategy, minimally disturbing membrane composition while depriving rafts of a necessary component (Scheiffele et al., 1997; Harder et al., 1998; Keller and Simons, 1998). Other cholesterol–protein interactions, however, may contribute to nAChR constraint (Gimpl et al., 2002; Allen et al., 2007). The fact that COase treatment did not increase α7-nAChR mobility on sympathetic neurites, though F-actin disruption did, indicates that cell types vary in their constraining mechanisms and that cholesterol depletion need not be toxic.
Both cholesterol depletion by COase or MβCD and disruption of postsynaptic PDZ scaffolds by CRIPT or PSD-95/SAP102 RNAi selectively freed up a portion of immobile α3*-nAChRs but not immobile α7-nAChRs on CG neurons. The fraction of α3*-nAChRs that remained immobile on neurites after treatment was comparable in size to the fraction of immobile α7-nAChRs found under all conditions. CRIPT had no effect on the lateral diffusion of already mobile α3*-nAChRs. Paradoxically, it did increase the mobility of α7-nAChRs without changing the proportion of α7-nAChRs that was mobile. Combining a mixture of disrupters with the CRIPT expression (to acutely disrupt microtubules, F-actin, and lipid rafts in addition to chronic disruption of PDZ-links) produced no further decrease in the fraction of immobile receptors. The CRIPT and COase treatments may have generated equivalent outcomes because they targeted a shared mechanism, e.g., the clustering of palmitoylated PDZ-proteins in a lipid raft (El-Husseini et al., 2002). The receptor-specific effects caused by disrupting PDZ scaffolds may be determined by the individual PSD-95 family members that interact with α3*-nAChRs versus α7-nAChRs, conferring different types of constraint (Conroy et al., 2003). The fact that the SAP102-GK construct acted as a dominant negative provided evidence that the PDZ scaffold constrains receptor mobility by linking them to sites via a GK domain. It has recently been shown that the GK domain of SAP102 is, in fact, responsible for stabilizing the protein at the postsynaptic density (Zheng et al., 2010).
Mechanisms shown here to constrain receptor mobility have been shown to stabilize receptor clusters. Disruption of lipid rafts and collapse of F-actin, for example, each disperses the large α7-nAChR clusters found on freshly dissociated CG neuron cell bodies (Shoop et al., 2000; Brusés et al., 2001; Liu et al., 2008). Disruption of PSD-95 family PDZ scaffolds in CG neurons via CRIPT expression or PSD-95/SAP102 RNAi significantly decreases synaptic α3*-nAChRs in culture (Neff et al., 2009). Disruption of PDZ scaffolds also interferes with signal transduction and downstream signaling by nAChRs, indicating the importance of receptor positioning (Conroy et al., 2003). Further, PSD-95/SAP102 RNAi decreases paired-pulse depression at synapses on CG neurons (Neff et al., 2009). Some of this latter effect may reflect increased receptor mobility providing rapid receptor exchange that diminishes the effects of desensitization, a phenomenon reported for AMPA receptors (Heine et al., 2008; Frischknecht et al., 2009). Lateral mobility would appear to be important for recruiting nAChRs to desired locations if receptor localization can then be stabilized.
Changes in receptor mobility did not necessarily induce a measurable change in either synaptic dwell time or frequency of transitions. This was true for diffusion of mobile α7-nAChRs on CG neurons following CRIPT disruption of PDZ scaffolds. Similarly, F-actin collapse by latrunculin A increased diffusion of mobile α7-nAChRs without changing either their synaptic dwell time or transition frequency. The results suggest that synaptic retention of mobile receptors may not simply reflect slower movement. Instead the receptors may be physically constrained either by a molecular border around the space or by a constraint that tethers them within the space (O'Connell et al., 2006; Triller and Choquet, 2008). This would be consistent with the observed MSD plots asymptotically approaching maximum values.
The large cytoplasmic loop of neuronal nAChRs can be critical for determining receptor location (Williams et al., 1998). Heteropentameric α3*-nAChRs on CG neurons are heterogeneous with respect to subunit composition. All contain α3 and β4 subunits, but only some contain β2 subunits and some, but perhaps not all, contain α5 subunits (Conroy and Berg, 1995). This heterogeneity may explain why α3*-nAChRs do not respond as a homogeneous population to disruptions of the cytoskeleton, lipid rafts, or PDZ scaffolds. Even α7-nAChRs, which were thought to be exclusively homopentameric (Drisdel and Green, 2000), may in some cases be heteropentameric (Khiroug et al., 2002; Liu et al., 2009). Alternatively, the finding that not all receptors of a given class appear to be constrained by the same component may result from the restraining component being present in limited amounts.
In the CNS multiple kinds of nAChRs exist, and they exert numerous effects depending on location and synaptic target (Picciotto et al., 1995; Newhouse et al., 1997; Bannon et al., 1998; Marubio et al., 1999; Mansvelder and McGehee, 2002; Picciotto and Zoli, 2002; Raggenbass and Bertrand, 2002; Maskos et al., 2005; Bitner et al., 2007; Teper et al., 2007). Lateral mobility allows nAChRs to be available for quick recruitment. Our results suggest that subunit-specific interactions with cytoskeletal and scaffold components are likely to be key determinants in constraining otherwise mobile nAChRs to unique locations according to individual receptor subtype and cell identity.
Footnotes
Grant support was provided by the National Institutes of Health (NS012601, N0S35469, and American Recovery and Reinvestment Act of 2009 stimulus funds) and the Tobacco-Related Disease Research Program (16RT-0167). C.C.F. is a Fundação Calouste Gulbenkian Graduate Fellow; D.G.V. is a Fundación para la Investigación Científica y Técnica Postdoctoral Fellow and a Tobacco-Related Disease Research Program Postdoctoral Fellow. We thank Tobias Köhl for his help and advice on developing tools for analysis of single-particle tracking. We thank Xiao-Yun Wang for expert technical assistance.
- Correspondence should be addressed to David Gómez-Varela, Neurobiology Section, Division of Biological Sciences, 0357, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0357. dgomezvarela{at}ucsd.edu